Twinbeech Capital LP Arcellx, Inc. Transaction History

Twinbeech Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$49.74 - $66.98 $1.15 Million - $1.55 Million	23,141 Added 76.01%	53,585 $2.96 Million
Q1 2024 May 15, 2024	SELL	$51.85 - $73.49 $1.71 Million - $2.43 Million	-33,020 Reduced 52.03%	30,444 $2.12 Million
Q4 2023 Feb 14, 2024	BUY	$31.75 - $57.99 $2.01 Million - $3.68 Million	63,464 New	63,464 $3.52 Million
Q2 2023 Aug 14, 2023	BUY	$27.49 - $46.9 $898,043 - $1.53 Million	32,668 New	32,668 $1.03 Million

204

44.1M

2.23M

907K

Ticker ACLX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,819,200
Market Cap $2.99B
Description
Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.